Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis
British Journal of Hospital Medicine · 30.08.2024 · 85 (8) · 1-41
DOI: 10.12968/hmed.2024.0347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, erschienen am 30.08.2024. Verfasst von Rong Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Hydrogels, Arthritis, Rheumatoid, Osteoarthritis, Drug Delivery Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 219 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis and rheumatoid arthritis, though etiologically distinct, are both inflammatory joint diseases that cause progressive joint injury, chronic pain, and loss of function. Therefore, long-term treatment with a focus on relieving symptoms is needed. At present, the primary treatment for arthritis is drug therapy, both oral and intravenous. Although significant progress has been achieved for these treatment methods in alleviating symptoms, certain prominent drawbacks such as the substantial side effects and limited absorption of medications call for an urgent need for improved drug delivery methods. Injected hydrogels can be used as a delivery system to deliver drugs to the joint cavity in a controlled manner and continuously release them, thereby enhancing drug retention in the joint cavity to improve therapeutic effectiveness, which is attributed to the desirable attributes of the delivery system such as low immunogenicity, good biodegradability and biocompatibility. This review summarizes the types of injectable hydrogels and analyzes their applications as delivery systems in arthritis treatment. We also explored how hydrogels counteract inflammation, bone and cartilage degradation, and oxidative stress, while promoting joint cartilage regeneration in the treatment of osteoarthritis (OA) and rheumatoid arthritis (RA). This review also highlights new approaches to developing injectable hydrogels as delivery systems for OA and RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Zitieren
APA
Zhu, R., Liao, H. Y., Huang, Y. C., & Shen, H. L. (2024). Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis. British Journal of Hospital Medicine, 85(8), 1-41. https://doi.org/10.12968/hmed.2024.0347
Vancouver
Zhu R, Liao HY, Huang YC, Shen HL. Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis. British Journal of Hospital Medicine. 2024;85(8):1-41. doi:10.12968/hmed.2024.0347
BibTeX
@article{Zhu2024,
author = {Zhu, Rong and Liao, Hai-Yang and Huang, Yi-Chen and Shen, Hai-Li},
title = {Application of Injectable Hydrogels as Delivery Systems in Osteoarthritis and Rheumatoid Arthritis},
journal = {British Journal of Hospital Medicine},
year = {2024},
volume = {85},
number = {8},
pages = {1--41},
doi = {10.12968/hmed.2024.0347}
}
EUVIMED